2nd Structural Heart Disease Asia Pacific
Symposium

1,2,3 June 2017, Auckland, New Zealand





Register

Bringing Together
Structural Heart Disease Interests.


SHD-AP symposium is designed for professionals involved in structural heart disease management.
Clinicians, Nurses, Health Policy Advisors, Hospital Management Staff and other allied health professionals.

        Live case transmissions of structural heart disease intervention
        Expert panel commentary on “case in a box” sessions on novel surgical and trans catheter techniques
        Interactive workshops on 4D Cardiac CT, 3D echocardiography
        Lecture series on technology integration - emerging 3D intra cardiac echo cardiography and real time fusion imaging.
        Wet dissection of the heart - focussed anatomical correlation with contemporary cardiac imaging.
        Interactive session with policy makers, hospital managers and clinicians.
        Biotechnology entrepreneurship programme
        Crew resource management - lessons from aviation industry for the heart teams
        “Internet of Things & Cardiology” - concepts for next generation cardiologists






Course Directors








Dr Sanjeevan Pasupati

Specialist in Coronary & Structural Disease Intervention

Dr Rajesh Nair

Specialist in Coronary & Structural Disease Intervention

Dr Pranesh Jogia

Specialist in Intensive Care & Cardiac Imaging























International Plenary Speakers










Dr. Feldman received his undergraduate and medical training at Indiana University, completing residency as Chief Resident at Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois. After finishing his Cardiology Fellowship at the University of Chicago, he remained there as Professor of Medicine and Director of the Cardiac Catheterization Laboratory. He currently practices at Evanston Hospital, where he is Director of the Cardiac Catheterization Laboratory, holds the Walgreen Chair in Interventional Cardiology, and is Professor of Clinical Medicine at University of Chicago Medical School. He has authored over 600 manuscripts, chapters, abstracts, and editorials and edited or co-edited several books. He is a Percutaneous Coronary Intervention Guideline co-author and has served on the American Board of Internal Medicine Interventional Cardiology test writing committee. Chicago Magazine has repeatedly named him among Chicago’s Top Doctors. Dr. Feldman is a past-President of the Society of Cardiovascular Angiography & Interventions, and chaired the Annual Scientific Sessions of the Society, as well as the American College of Cardiology Annual Meeting Interventional Sessions. He is an active interventional practitioner and performs hundreds of catheter procedures every year. He has been the national principal investigator of the EVERESTI and II MitraClip trials, REPRISE III TAVR trial, and CorVia REDUCE LAP trial. He participates in numerous clinical investigations, with major research interests that include non-surgical, percutaneous repair and replacement of the mitral valve, catheter based aortic valve replacement, device closure for paravalavular leak and congenital heart disease, left atrial appendage closure, and development of novel catheter devices.

Dr Ted Feldman

Past President, SCAI;Director, Cardiac Catheterization Laboratory, NorthShore University HealthSystem, Evanston Hospital Illinois, USA

José L. Navia, MD, is a staff surgeon in the Department of Thoracic and Cardiovascular Surgery in the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He earned his medical degree from the School of Medicine at the National University of La Plata in Buenos Aires, Argentina. He completed his internships and residencies in general surgery, cardiovascular surgery and cardiothoracic surgery in Argentinian hospitals.
Dr. Navia received a fellowship in cardiothoracic surgery from the Cleveland Clinic in 1994. During his fellowship and residency at Cleveland Clinic, Dr. Navia served as Chief Resident for one year. He has received the Rene Favaloro International Fellow Award and the Dr. Charles H. Bryan Clinical Excellence Award. He joined the Cleveland Clinic Heart & Vascular Institute in 1998 following an appointment at the Italian Hospital in Buenos Aires as a staff surgeon in the Department of Thoracic and Cardiovascular Surgery. He has also received The Cleveland Clinic Innovator Award every year from 2004 through 2016, as well as the 1 st Annual Sones Favaloro Scientific Awards in Innovations, from Cleveland Clinic Heart and Vascular Institute, HVI 2015.
Dr. Navia serves as a Surgical Member, Executive Committee of the Cleveland Clinic/Heart & Vascular Institute/Cardiothoracic Surgery, and as a Co-Chairman, Heart and Vascular Institute Peer Review Innovations Committee.

Dr. Navia has been a principal and co-investigator for several clinical research trials. Dr. Navia’s research focuses on robotic cardiac surgery, video-assisted minimally invasive cardiac surgery aortic, mitral, and tricuspid valve repair and replacement, and a stentless mitral valve — an original design for mitral valve replacement that is being used across the country. He has developed different cannulas (tubes for needles and surgical instruments) for pulmonary bypass and has designed a proximal anastomosis device to avoid clamping the aorta during cardiac surgery. He has also developed novel surgical annuloplasty rings for functional mitral and tricuspid valve regurgitation treatment, as well as a transcatheter.
mitral and tricuspid valve ring and prosthesis.
He is extensively involved in research to investigate new and more effective treatments for patients with heart failure, such as advances in cardiac resynchronization therapy and mechanical circulatory device therapy.
Dr. Navia is a national leader in successfully and safely utilizing various techniques in minimally invasive off-pump bypass surgery, as well as a surgical treatment of complex multivalve endocarditis, aortic valve homograft surgery, Commando Procedure with Aortic and mitral homografts, and multiple valve cardiac reoperations.
Dr. Navia has published many articles and abstracts in national and international professional publications and is a manuscript reviewer and editorial board member for several medical journals. Dr. Navia organizes seminars and symposia on advanced topics in cardiothoracic surgery and presents his work at major international conferences with leading physicians from around the world.
About Dr. Navia: “My greatest strength as a heart surgeon is the ability to treat patients with even the most complex medical problems. Many times, these treatments involve advanced techniques and innovative approaches to achieve the best possible results. I have a passion for innovation, and it is extremely gratifying to invent a new way to help a patient who otherwise may not have been able to have a good outcome.”
Leisure Activities: Dr. Navia enjoys spending time with his family, especially on the beaches of Argentina and skiing together in the winter.
Languages Spoken: English, Italian, Spanish

Dr Jose Navia

Thoracic and Cardiovascular Surgeon Cleveland Clinic Cleveland, USA

Dr Carlos Ruiz

Professor of Cardiology in Paediatrics and Medicine Director of Structural and Congenital Heart Disease Program Hackensack University Medical Center, NY, USA

R. C. Quijano,President and CEO. Dr. Quijano founded Xenomedica AG in Switzerland sold to Edwards Laboratories (American hospital Supply, later Baxter Healthcare) after 5 years of function. Founded and was President and Chief Technical Officer of VenPro corporation that sold the Contegra Pulmonary Valved Conduit and Percutaneous Pulmonary Valved Stent (later named Melody, the first valve implanted into a human in the world) to Medtronic in 2003; founded in 1999 and was President of 3f Therapeutics, manufacturer of the 3f Stentless aortic valve, and the Enable Sutureless implantation aortic valve (the first cardiac valve implanted without need of sutures). 3f sold to ATS medical in 2006 on a share exchange and ATS subsequently sold to Medtronic in 2010. He is presently, as Founder of NCSI, President and CEO of this 4-year old startup company based in Southern California. NCSI is developing AtrioVentricular Valved stents, to be implanted with a Catheter. The first Mitral valve was implanted TransAtrially in a patient’s beating heart in Chile in October 2015 and at more than 15 months the patient continues to do well. In November 2016, a patient at the Cleveland Clinic was received the World’s First Tricuspid valve TransAtrially with catheter guidance in a beating heart. The patient at more than 3 months is doing well.

Dr Rodolfo Constantino (Tino) Quijano.

Founder, President and CEO,Navigate Cardiac Structures Inc.

















Faculty









Mr Adam El Gamel

Cardiothoracic Surgeon, Waikato DHB, Hamilton, New Zealand

Mr Andrew McCurdie

Chief Financial Officer, Waikato DHB, Hamilton, New Zealand

Dr Andrew To

Consultant Cardiologist, Waitemata DHB Auckland, New Zealand

A/Prof Alex Sasse

Consultant Cardiologist, Wellington Hospital Wellington, New Zealand

Dr Brian Chan

Anaesthetist, Waikato DHB, Hamilton, New Zealand

Dr Carlos Ruiz

Professor of Cardiology in Paediatrics and Medicine Director of Structural and Congenital Heart Disease Program Hackensack University Medical Center, NY, USA

Dr C N Manjunath

Mr David McCormack

Cardiothoracic Surgeon, Waikato DHB, Hamilton, New Zealand

Dr David Muller

Interventional Cardiologist, St Vincent’s Clinic Sydney, Australia

Dr David Roy

Interventional Cardiologist, St Vincent's Hospital, Sydney,Australia

Dr David Smyth

Interventional Cardiologist, Canterbury DHB, Christchurch, New Zealand

Dr Dennis Wang

Interventional Cardiologist, Specialist Cardiology, Sydney, Australia

Darrin Hackett

Executive Director of Virtual Care and Innovation, Waikato Hospital, Hamilton, NZ

Dr Gerry Wilkins

Interventional Cardiologist, Southern DHB, Dunedin, New Zealand

Dr Gerald Yong

Interventional Cardiologist, Perth Cardiovascular Institute, Perth, Australia

Mr Indran Ramanathan

Cardiothoracic Surgeon, Auckland DHB, Auckland, New Zealand

Prof John Ormiston

Interventional Cardiologist, Mercy Angiography Ltd, Auckland, New Zealand

Dr Jason Sharp

Interventional Cardiologist, Specialist Cardiology, Sydney, Australia

Dr Jim Stewart

Interventional Cardiologist, Auckland DHB, Auckland, New Zealand

Dr Jose Navia

Thoracic and Cardiovascular Surgeon Cleveland Clinic Cleveland, USA

Jacinta Nathan

Dr Karl Poon

Interventional Cardiologist, Queensland Cardiovascular Group, Brisbane,Australia

Dr Krys Milburn

Interventional Cardiologist, Southern DHB Dunedin, New Zealand

Ms Kylie Anderson

Mr Lee Robinson

Training Manager Human Factors, Air New Zealand

Dr Mark Davis

Interventional Cardiologist, Waikato DHB, Hamilton, New Zealand

Mr Mahesh Nair

CEO, Cirakas Consulting Pvt. Ltd., Thiruvananthapuram, India

Ms Michelle Klenner

Mr Nand Kejriwal

Dr Pranesh Jogia

Specialist in Intensive Care & Cardiac Imaging

Dr Rajesh Nair

Specialist in Coronary & Structural Disease Intervention

A/Prof Ravinay Bhindi

Interventional Cardiologist, University of Sydney, Sydney, Australia

Dr Sanjeevan Pasupati

Specialist in Coronary & Structural Disease Intervention

Dr Stephen Duffy

Prof Sean Galvin

Cardiothoracic Surgeon, Capital & Coast DHB, Wellington, New Zealand

Dr Tino Quijano

Founder, President and CEO,Navigate Cardiac Structures Inc.

Dr Ted Feldman

Past President, SCAI;Director, Cardiac Catheterization Laboratory, NorthShore University HealthSystem, Evanston Hospital Illinois, USA

Dr Tony Walton











Agenda


* Please note that this programme is provisional, and subject to change at any time without notice.

Download a PDF copy of the Agenda HERE

THURSDAY, 1 JUNE , 2017


SCHEDULE TOPICS SPEAKERS
08:00 Registration Desk Open
08:45 - 09:00 Welcome Course directors
WORKSHOPS
09:00 - 12:30 WORKSHOP A: Wet Dissection - Applied Clinical Anatomy - Perspectives from SHD Cardiologists and Cardiac Surgeon
09:00 - 10:30 Right atrium, inter atrial septum, tricuspid valve Dr Rajesh Nair, Mr David McCormack, Mr Nand Kejriwal
10:30 - 11:00 Morning Tea
11:00 - 12:30 Left atrium, mitral valve, aortic valve Dr Pranesh Jogia, Dr Sanjeevan Pasupati, Mr David McCormack, Mr Nand Kejriwal
12:30 - 13:30 Lunch
13:30 - 14:30 Image Acquisition for Structural Heart Disease Chairs:- Dr Rajesh Nair, Dr Pranesh Jogia
13:30 - 14:00 Acquisition of cardiac CT for structural heart disease Dr Sanjeevan Pasupati
14:00 - 14:30 Trans oesophageal echo tips and tricks for SHD intervention Dr Mark Davis
Concurrent workshops
14:45 - 18:00 CONCURRENT WORKSHOP B: Cardiac CT for Structural Heart Disease Panel:- Dr Sanjeevan Pasupati - Horos/Osirix
Dr Pranesh Jogia - Vitrea
Dr Rajesh Nair, Vern Gall - Circle
14:45 - 16:00 Aortic valve - TAVI planning
16:00 - 16:15 Afternoon Tea
16:15 - 18:00 Overview of:
Mitral valve
Left atrial appendage
4D cardiac CT - VSD
14:45 - 18:00 CONCURRENT WORKSHOP C: 3D TOE ECHO - Image Manipulation Panel:- A/Prof Alex Sasse, Ms Michelle Klenner - GE Healthcare
Dr Mark Davis, Ms Kylie Anderson - Philips/Life Healthcare
14:45 - 18:00 Atrial septal defects
16:00 - 16:15 Afternoon Tea
16:15 - 18:00 Mitral valve segmentation
Aortic valve - TAVI planning











FRIDAY, 2 JUNE , 2017


SCHEDULE TOPICS SPEAKERS
08:00 - 10:00
Aortic Valve
Chairs:- Dr David Smyth, Mr Indran Ramanathan
Panel:- Dr Sanjeevan Pasupati, Dr Ted Feldman, Dr Jim Stewart, Dr Gerald Yong, Mr Adam El-Gamel
08:00 - 08:15 Introduction Dr Pranesh Jogia
08:15 - 09:00 Aortic valve interventions - past, present, future Dr Ted Feldman
09:00 - 09:30 Innovations in surgical aortic valve therapies Mr Adam El-Gamel
09:30 - 10:00 Practicalities of running TAVI programme - valve choices, balloon aortic valvuloplasty Dr Sanjeevan Pasupati
10:00 - 10:15 Morning Tea
10:15 - 13:00
Contemporary Transcatheter Therapies
Chairs:- Dr Sanjeevan Pasupati, Mr Adam El-Gamel
Panel:- Dr Ted Feldman, Dr David Muller, Dr Gerald Yong, Dr Jim Stewart, Dr David Roy, Dr Karl Poon
10:15 - 11:00 TAVI - Edward valve - "Case in a Box" Dr Jim Stewart
11:00 - 12:30 Live Case from the Alfred Hospital, Melbourne - Evolute R Corevalve Dr Tony Walton, Dr Stephen Duffy, Jacinta Nathan
12:30 - 13:00 Transcatheter therapies - is it cost effective in the real world Mr Andrew McCurdie
13:00 - 13:30 Lunch
13:30 - 15:45
Complex Cardiac Intervention
Chairs: - Dr Gerry Wilkins, Mr Nand Kejriwal
Panel: - Dr Jose Navia, Dr Carlos Ruiz, Dr Mark Davis, Dr Ravinay Bhindi, Dr David Muller, Dr Sanjeevan Pasupati
13:30 - 14:15 Redo cardiac surgery vs role for transcatheter therapies Dr Jose Navia
14:15 - 15:45 Live Case from The Alfred Hospital, Melbourne - Fusion Imaging for SHD intervention - MitraClip/Para valvular leak closure Dr Tony Walton, Dr Stephen Duffy, Jacinta Nathan
15:45 - 16:00 Afternoon Tea
16:00 - 17:15
Safety in Complex Interventions
Chairs: - Dr Pranesh Jogia, Dr Gerry Wilkins
Panel: - Mr Lee Robinson, Dr Brian Chan, Dr David Roy, Dr David Smyth, A/Prof Alex Sasse, Dr Andrew To
16:00 - 16:45 Lessons from aviation - Safety culture Mr Lee Robinson
16:45 - 17:15 Anaesthesia in the era of trans catheter therapies Dr Brian Chan











SATURDAY, 3 JUNE , 2017


SCHEDULE TOPICS SPEAKERS
07:30 - 08:30 Siemens Breakfast Session
3D Intra cardiac echo - clinical applications
Dr Rajesh Nair
09:00 - 10:15
Transcatheter Mitral Valve Therapies
Chairs: - A/Prof Alex Sasse, Mr Sean Galvin
Panel:- Dr Jose Navia, Dr Ted Feldman, Dr David Muller, Dr Mark Davis, Mr Adam El-Gamel, Dr Dennis Wang
09:00 - 09:45 Trans catheter mitral valve therapies - past, present and future Dr Ted Feldman
09:45 - 10:15 ANZ mitral valve experience Dr David Muller
10:15 - 10:30 Morning Tea
10:30 - 13:00
Advanced Technologies
Chairs: - Dr Sanjeevan Pasupati, Dr Rajesh Nair
Panel: - Dr Jose Navia, Dr Tino Quijano, Mr Indran Ramanathan, Dr Gerry Wilkins, Dr Krys Milburn, Dr Jason Sharp
10:30 - 11:15 The forgotten valve - tricuspid valve therapies Dr Jose Navia
11:15 - 11:45 Biotechnology entrepreneurship Dr Tino Quijano
11:45 - 12:00 Internet of things Mr Mahesh Nair
12:00 - 12:30 "Case in a Box"
12:30 - 13:00 Para valvular leak closure - "Case in a Box" Dr Gerry Wilkins
13:00 - 13:45 Lunch
13:45 - 17:00
International Session
Chairs: - Dr Carlos Ruiz, Dr Ravinay Bhindi
Panel: - Dr David Roy, Dr Jason Sharp, Dr Dennis Wang, Dr Gerald Yong, Dr Karl Poon, Dr David Muller
13:45 - 14:30 Left atrial appendage closure - "Case in a Box" Dr Jason Sharp, Dr Dennis Wang
14:30 - 15:30 Live Case from Sri Jayadeva Institute of Cardiovascular Sciences and Research, India - Percutaneous balloon mitral valvuloplasty Dr C N Manjunath
15:30 - 16:00 Next generation dynamic fusion imaging of the heart Dr Carlos Ruiz
16:00 - 17:00 Live Case from Sri Jayadeva Institute of Cardiovascular Sciences and Research, India - Device closure of shunt lesions (VSD/PDA) Dr C N Manjunath
14:00 - 16:00
Concurrent Session
Chairs: - Dr Rajesh Nair, Mr Adam El-Gamel
Panel: - Dr David Smyth, Dr Sanjeevan Pasupati, Dr Gerry Wilkins, Dr Pranesh Jogia, Prof John Ormiston, Dr Jim Stewart
14:00 - 14:30 Structural heart disease - Equity of care across New Zealand Dr Gerry Wilkins
14:30 - 15:00 Evolving trends in NZ private practice - SHD perspective Prof John Ormiston
15:00 - 15:30 Integrating innovation and technology in the NZ public health medical system Darrin Hackett
15:30 - 16:00 Discussion
17:00 - 17:10 Closing remarks Course Directors
















Workshops

Workshops are designed to provide hands on experience for attendees to be familiar with image manipulation software. Attendees will learn basic concepts of cardiac imaging and its use in everyday practise.

Workshops are part of the symposium. However places will be limited to provide best practical training. There may be up to 3 attendees in each dedicated work station. Please register separately for the workshop & slots will be awarded on a first in first serve basis.






*  Attendance at either the Cardiac CT or 3D TOE ECHO workshop is included in the symposium registration fee. The first 20 spaces in the Wet Dissection workshop will also be included in the registration fee – thereafter, the cost to attend will be $50.



The Difference between ordinary and extraordinary is just that little extra

ALBERT EINSTEIN

The Desire to Create is One of the Deepest Yearnings of the Human Soul

DIETER F. UCHTDORF


















Event Sponsors

Platinum


Gold


  • client


Silver


























Register Today

Earlybird registration closes Sunday 30 April 2017

* An additional charge of $50 (Specialist/Physician and Allied Health) and $100 (Medical Industry) will be added to the fee for registrations received from 1 May.


REGISTRATION FEES *



Specialist/Physician



$800NZD




Register




Medical Industry



$1000NZD




Register




Allied Health



$500NZD




Register




Fellow/Trainee/Registrar



$500NZD




Register




Day Registration



$450NZD




Register


* All prices are quoted in New Zealand dollars and include GST of 15%.
* Three day admission includes Symposium sessions, Industry exhibitions & Catering.

PAYMENT TERMS AND CONDITIONS ACCOMMODATIONNZ IMMIGRATION

PAYMENT

All delegates are required to officially register, and full payment is required in order to attend the symposium.Payment can be made on invoice by selecting the Pay by Direct Credit/ Internet Banking option during the online registration process (account details will be included on your invoice), or by credit card (Visa or Mastercard only). Credit card payments will incur a 3% surcharge, and will show debit as Outshine Ltd.

On submission of your registration a confirmation will be emailed to you, with your tax invoice/receipt attached.


To amend any registration details, or to cancel your registration, please contact the Symposium Managers via email at joanna@outshine.co.nz, or phone +64 7 823 1910.

TERMS AND CONDITIONS

Cancellations

All cancellations must be made in writing to the Symposium Managers at joanna@outshine.co.nz. Cancellations made prior to 1 May 2017 will be refunded less $100 to cover administration costs. No registration refunds will be made after this date, and refunds for tickets to any social functions will be assessed on a case by case basis. You may elect to reassign your registration, in which case please contact the Symposium Managers with the replacement delegate contact details. If, for reasons beyond the control of the Course Directors, the SHD-AP Symposium is cancelled, the registration fees will be refunded after deduction of expenses already incurred.


Photography/ Video

The SHD-AP Symposium is held in a public space, therefore we do not prohibit participants, exhibitors, sponsors, news organizations and other companies from photographing or video or audio-taping some symposium activities. Additionally, SHD-AP may arrange for photos to be taken during the symposium. SHD-AP reserves the right to use images taken at the symposium with your photograph and/or likeness in future marketing materials, including on the internet. The Symposium Managers may also use images taken at the symposium with your photograph and/or likeness in future marketing materials, including on the internet, with the permission of SHD-AP. Symposium attendees who prefer their images are neither taken nor published in any format, have the ability to object by sending an email request to the Symposium Managers at joanna@outshine.co.nz.

Health & Safety

The Symposium Managers, in conjunction with the SHD-AP Course Directors and the Venue, are committed to providing and maintaining a safe and healthy symposium environment for all attendees, and to providing the information needed to achieve this. The Symposium Managers, in conjunction with the SHD-AP Course Directors and the Venue, will take responsibility for providing health and safety procedures whilst onsite, however, all symposium attendees need to be aware of their own responsibilities.

Each symposium attendee is encouraged to play a vital and responsible role in maintaining a safe and healthy symposium environment through:


  • Listening to the health and safety briefing onsite and/or;
  • Reading the health and safety procedure document provided onsite at the registration desk;
  • Ensuring all accidents and incidents that occur onsite at the symposium are reported;
  • Informing the Symposium Managers, one of the SHD-AP Course Directors or a staff member at the Venue immediately of any health and safety concerns;
  • Respecting your own personal safety and that of other symposium delegates and employees.

ACCOMMODATION

Symposium rates have been secured at the Pullman Hotel, and accommodation can be booked during the online registration process.

SHD-AP Symposium Rate - $215.00 per room per night, inclusive of GST and based on single, twin or double occupancy.

It is strongly recommended that you register and book your accommodation prior to Sunday 23 April 2017. After this date, any remaining rooms will be released and bookings will be subject to availability.

**Please note, the Lions' International rugby tour is occurring at the same time as the SHD-AP Symposium. Alternative accommodation will likely be extremely limited in Auckland, and may be subject to surcharges and premium rates**

Accommodation cost is delegates' own, and full payment should be made directly to the hotel on check-out (your credit card details will be requested during registration to secure your booking only). Cancellation of rooms within 30 days of arrival, incurs a cancellation fee of 100% of the full accommodation cost. A "no-show" will also result in a 100% charge to the delegates' credit card. Please note, any cancellations must be made directly with the Symposium Managers, and not with the hotel.









Get In Touch
Contact Us

We would like to hear from you.

Symposium Manager
Outshine Ltd
PO Box 896, Cambridge 3450, New Zealand
p. +64 7 823 1910
e.  jo@outshine.co.nz